Back to BlackRock, Inc. BlackRock, Inc.

ATRAATRA
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ATARA BIOTHERAPEUTICS INC

BlackRock, Inc. holds 84,455 shares of ATRA (ATARA BIOTHERAPEUTICS INC), worth $969,544 as of 2026-Q2. The position was increased (+6.9% shares).

Current Value

$969,544

Current Shares

84,455

Total Value Change

+$159,683

Total Shares Change

+23,609

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
84,455
+6.9%
$969,5440.0%$11.48
18
2026-Q1
Increased
79,022
+17.8%
$373,7730.0%$5.42
19
2025-Q4
Decreased
67,108
-3.9%
$1.2M0.0%$17.88
0
2025-Q3
Decreased
69,833
-1.4%
$1M0.0%$13.81
0
2025-Q2
Increased
70,848
+16.5%
$546,9460.0%$7.96
19
2025-Q1
Decreased
60,798
-0.1%
$361,1400.0%$6.53
0
2024-Q4
New
60,846
-
$809,8610.0%$13.28
38

Other major holders of ATRA: ADAGE CAPITAL PARTNERS GP, L.L.C., Point72 Asset Management, L.P., VANGUARD GROUP INC, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used